NCT01491737 · Interventional trial
A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast Cancer
Overall registry status Completed
Phase 2
Conditions Breast Cancer
Delaware Valley sites
- Cooper Hospital; Hematology & Oncology · Voorhees Township, NJ · Camden County
First posted
Registry updated
Added to the directory